We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+4.27%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$56.6B
AUM Growth
-$4.33B
(-7.1%)
Cap. Flow
-$5.51B
Cap. Flow
% of AUM
-9.73%
Top 10 Holdings %
Top 10 Hldgs %
36.93%
Holding
1,739
New
42
Increased
177
Reduced
1,384
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$201M |
| 2 |
Oracle
ORCL
|
+$135M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$123M |
| 4 |
Invesco MSCI USA ETF
PBUS
|
+$80.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$63M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$267M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$183M |
| 3 |
NVIDIA
NVDA
|
+$172M |
| 4 |
JPMorgan Chase
JPM
|
+$137M |
| 5 |
Apple
AAPL
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.12% |
| 2 | Financials | 12.63% |
| 3 | Healthcare | 12.38% |
| 4 | Communication Services | 10.27% |
| 5 | Consumer Discretionary | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
LiveRamp
RAMP
$2.29B
| $172K | ﹤0.01% |
5,853
-16,150
| -73% | -$464K |
|
1377
DigitalBridge
DBRG
$2.93B
| $171K | ﹤0.01% |
11,135
-19,100
| -63% | -$230K |
|
1378
Celldex Therapeutics
CLDX
$2.79B
| $171K | ﹤0.01% |
6,278
-9,600
| -60% | -$253K |
|
1379
DNOW Inc
DNOW
$2.53B
| $170K | ﹤0.01% |
12,842
-14,550
| -53% | -$204K |
|
1380
Apogee Therapeutics
APGE
$10.1B
| $170K | ﹤0.01% |
+2,250
| New | +$142K |
|
1381
Avient
AVNT
$3.41B
| $170K | ﹤0.01% |
5,436
-13,850
| -72% | -$429K |
|
1382
Addus HomeCare
ADUS
$2.23B
| $170K | ﹤0.01% |
1,579
-3,650
| -70% | -$419K |
|
1383
Pediatrix Medical
MD
$2.21B
| $169K | ﹤0.01% |
7,904
-19,900
| -72% | -$408K |
|
1384
Remitly
RELY
$4.91B
| $169K | ﹤0.01% |
12,250
-29,900
| -71% | -$434K |
|
1385
Chesapeake Utilities
CPK
$3.31B
| $169K | ﹤0.01% |
1,352
-4,200
| -76% | -$554K |
|
1386
Allegro MicroSystems
ALGM
$8.29B
| $168K | ﹤0.01% |
6,366
-17,100
| -73% | -$471K |
|
1387
Immunovant
IMVT
$7.99B
| $168K | ﹤0.01% |
6,606
-15,700
| -70% | -$350K |
|
1388
Crane NXT
CXT
$3.14B
| $168K | ﹤0.01% |
3,561
-3,150
| -47% | -$186K |
|
1389
Euronet Worldwide
EEFT
$3.15B
| $167K | ﹤0.01% |
2,200
-10,760
| -83% | -$839K |
|
1390
Avis
CAR
$5.88B
| $167K | ﹤0.01% |
1,303
-2,800
| -68% | -$391K |
|
1391
Diamondrock Hospitality Co
DRH
$2.67B
| $167K | ﹤0.01% |
18,655
-61,200
| -77% | -$522K |
|
|
CPRX
1392
DELISTED
Catalyst Pharmaceutical
CPRX
| $167K | ﹤0.01% |
7,160
-13,850
| -66% | -$309K |
|
1393
Jack in the Box
JACK
$308M
| $167K | ﹤0.01% |
8,806
-560
| -6% | -$10.1K |
|
|
LTC
1394
LTC Properties
LTC
$2.14B
| $167K | ﹤0.01% |
4,845
-4,100
| -46% | -$145K |
|
1395
Quaker Houghton
KWR
$2.67B
| $167K | ﹤0.01% |
1,213
-2,900
| -71% | -$392K |
|
1396
Otter Tail
OTTR
$3.93B
| $166K | ﹤0.01% |
2,060
-3,000
| -59% | -$243K |
|
1397
Cedar Fair
FUN
$1.91B
| $166K | ﹤0.01% |
10,850
-7,800
| -42% | -$141K |
|
1398
Avista
AVA
$3.46B
| $166K | ﹤0.01% |
4,317
-2,600
| -38% | -$102K |
|
1399
Immunome
IMNM
$2.63B
| $165K | ﹤0.01% |
+7,700
| New | +$135K |
|
1400
BigBear.ai
BBAI
$1.32B
| $164K | ﹤0.01% |
30,450
-34,150
| -53% | -$223K |
|
Similar funds
SCP
Ensign Peak Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Ensign Peak Advisors held 1,739 positions worth $56.6B, down 7.1% from $60.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Ensign Peak Advisors withdrew a net $5.51B in Q4 2025, closing 54 positions and reducing 1,384 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ensign Peak Advisors opened a new position in Invesco MSCI USA ETF worth $81.3M.
- Ensign Peak Advisors's largest Q4 2025 buy was Invesco MSCI USA ETF: 1,188,232 shares worth $81.3M.
- Ensign Peak Advisors added most to Eli Lilly in Q4 2025, an estimated $201M increase.
- Ensign Peak Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $267M.
- Ensign Peak Advisors fully exited iShares Core S&P 500 ETF in Q4 2025, selling an estimated $125M.
- Ensign Peak Advisors's ten largest holdings make up 37% of its $56.6B portfolio in Q4 2025.
- Ensign Peak Advisors opened 42 new positions and closed 54 in Q4 2025.
- Ensign Peak Advisors's portfolio value fell 7.1% quarter-over-quarter to $56.6B.
Based on Ensign Peak Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.